Recent trends and technologies in Drug Discovery #Bioinformatics 2018

Modeling and simulation are valuable research and product development tools that are helping to advance regulatory science, according to the FDA.

The FDA is using modeling and simulation to help achieve its objectives of improving health care, broadening access and advancing public health goals, Tina Morrison, PhD, chair of FDA’s agency-wide modeling and simulation working group and regulatory advisor of computational modeling for FDA’s Office of Device Evaluation, said at an FDA Grand Rounds meeting.

Modeling and simulation can help predict clinical outcomes and product safety, inform clinical trial designs and support evidence of effectiveness, according to the FDA.

“Ideally, we’d like to be able to promote consistent review and decision-making with modeling and simulation,.

To know more about recent trends and technologies visit : https://bioinformatics.pulsusconference.com/call-for-abstracts

Kindly submit your abstracts : https://bioinformatics.pulsusconference.com/abstract-submission 

Book your slot by registering at :  https://bioinformatics.pulsusconference.com/registration